<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39408067</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>19</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>09</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>Arterial Thrombosis in Acute Respiratory Infections: An Underestimated but Clinically Relevant Problem.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">6007</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm13196007</ELocationID><Abstract><AbstractText>During the COVID-19 pandemic, there was increased interest in the issue of thrombotic complications of acute respiratory infections. Clinical reports and pathological studies have revealed that thrombus formation in COVID-19 may involve the venous and arterial vasculature. As thrombotic complications of infectious respiratory diseases are increasingly considered in the context of COVID-19, the fact that thrombosis in lung diseases of viral and bacterial etiology was described long before the pandemic is overlooked. Pre-pandemic studies show that bacterial and viral respiratory infections are associated with an increased risk of thrombotic complications such as myocardial infarction, ischemic stroke, pulmonary embolism, and other critical illnesses caused by arterial and venous thrombosis. This narrative review article aims to summarize the current evidence regarding thrombotic complications and their pathogenesis in acute lower respiratory tract infections.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Babkina</LastName><ForeName>Anastasiya S</ForeName><Initials>AS</Initials><Identifier Source="ORCID">0000-0003-1780-9829</Identifier><AffiliationInfo><Affiliation>Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow 107031, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pisarev</LastName><ForeName>Mikhail V</ForeName><Initials>MV</Initials><Identifier Source="ORCID">0000-0002-9647-1012</Identifier><AffiliationInfo><Affiliation>Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow 107031, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grechko</LastName><ForeName>Andrey V</ForeName><Initials>AV</Initials><AffiliationInfo><Affiliation>Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow 107031, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Golubev</LastName><ForeName>Arkady M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow 107031, Russia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ARDS</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">arterial thrombosis</Keyword><Keyword MajorTopicYN="N">pneumonia</Keyword><Keyword MajorTopicYN="N">respiratory infections</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>10</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>1</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39408067</ArticleId><ArticleId IdType="pmc">PMC11477565</ArticleId><ArticleId IdType="doi">10.3390/jcm13196007</ArticleId><ArticleId IdType="pii">jcm13196007</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cui S., Chen S., Li X., Liu S., Wang F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J. Thromb. Haemost. 2020;18:1421–1424. doi: 10.1111/jth.14830.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14830</ArticleId><ArticleId IdType="pmc">PMC7262324</ArticleId><ArticleId IdType="pubmed">32271988</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan W.J., Ni Z.Y., Hu Y., Liang W.H., Ou C.Q., He J.X., Liu L., Shan H., Lei C.L., Hui D.S.C., et al. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 2020;382:1708–1720. doi: 10.1056/NEJMoa2002032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2002032</ArticleId><ArticleId IdType="pmc">PMC7092819</ArticleId><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuckier L.S., Moadel R.M., Haramati L.B., Freeman L. Diagnostic evaluation of pulmonary embolism during the COVID-19 pandemic. J. Nucl. Med. 2020;61:630–631. doi: 10.2967/jnumed.120.245571.</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnumed.120.245571</ArticleId><ArticleId IdType="pubmed">32238427</ArticleId></ArticleIdList></Reference><Reference><Citation>Recommendations of the Russian Ministry of Health—Federal State Budgetary Institution “National Medical Research Center for Phthisiopulmonology and Infectious Diseases” of the Ministry of Health of the Russian.  [(accessed on 1 September 2024)].  Available online:  https://nmrc.ru/for_specialists/o-koronaviruse/rekomendatsii-minzdrava-rossii-2/</Citation></Reference><Reference><Citation>Zabolotskikh I., Kirov M., Lebedinskii K., Protsenko D., Avdeev S., Andreenko A., Arsentyev L., Afonchikov V., Afukov I., Belkin A. Anesthesia and intensive care for patients with COVID-19. Russian Federation of anesthesiologists and reanimatologists guidelines. Ann. Crit. Care. 2021;S1:9–143. doi: 10.21320/1818-474X-2021-S1-9-143.</Citation><ArticleIdList><ArticleId IdType="doi">10.21320/1818-474X-2021-S1-9-143</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 Rapid Guideline: Managing COVID-19.  [(accessed on 1 September 2024)].  Available online:  https://www.nice.org.uk/guidance/ng191/resources/covid19-rapid-guideline-managing-covid19-pdf-66142077109189.</Citation></Reference><Reference><Citation>Bikdeli B., Madhavan M.V., Jimenez D., Chuich T., Dreyfus I., Driggin E., Der Nigoghossian C., Ageno W., Madjid M., Guo Y., et al. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review. J. Am. Coll. Cardiol. 2020;75:2950–2973. doi: 10.1016/j.jacc.2020.04.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.04.031</ArticleId><ArticleId IdType="pmc">PMC7164881</ArticleId><ArticleId IdType="pubmed">32311448</ArticleId></ArticleIdList></Reference><Reference><Citation>Nardelli P., Landoni G. COVID-19-Related Thromboinflammatory Status: MicroCLOTS and Beyond (Editorial) Obs. Reanimatol. 2020;16:14–15. doi: 10.15360/1813-9779-2020-3-0-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.15360/1813-9779-2020-3-0-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng N.M., Chan Y.C., Cheng S.W. COVID-19 related thrombosis: A mini-review. Phlebology. 2022;37:326–337. doi: 10.1177/02683555211052170.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/02683555211052170</ArticleId><ArticleId IdType="pmc">PMC9006089</ArticleId><ArticleId IdType="pubmed">35403487</ArticleId></ArticleIdList></Reference><Reference><Citation>Lax S.F., Skok K., Zechner P., Kessler H.H., Kaufmann N., Koelblinger C., Vander K., Bargfrieder U., Trauner M. Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome: Results from a Prospective, Single-Center, Clinicopathologic Case Series. Ann. Intern. Med. 2020;173:350–361. doi: 10.7326/M20-2566.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-2566</ArticleId><ArticleId IdType="pmc">PMC7249507</ArticleId><ArticleId IdType="pubmed">32422076</ArticleId></ArticleIdList></Reference><Reference><Citation>Babkina A.S., Yadgarov M.Y., Volkov A.V., Kuzovlev A.N., Grechko A.V., Golubev A.M. Spectrum of Thrombotic Complications in Fatal Cases of COVID-19: Focus on Pulmonary Artery Thrombosis In Situ. Viruses. 2023;15:1681. doi: 10.3390/v15081681.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15081681</ArticleId><ArticleId IdType="pmc">PMC10458612</ArticleId><ArticleId IdType="pubmed">37632023</ArticleId></ArticleIdList></Reference><Reference><Citation>Violi F., Cangemi R., Calvieri C. Pneumonia, thrombosis and vascular disease. J. Thromb. Haemost. 2014;12:1391–1400. doi: 10.1111/jth.12646.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.12646</ArticleId><ArticleId IdType="pubmed">24954194</ArticleId></ArticleIdList></Reference><Reference><Citation>Warren-Gash C., Blackburn R., Whitaker H., McMenamin J., Hayward A.C. Laboratory-confirmed respiratory infections as triggers for acute myocardial infarction and stroke: A self-controlled case series analysis of national linked datasets from Scotland. Eur. Respir. J. 2018;51:1701794. doi: 10.1183/13993003.01794-2017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01794-2017</ArticleId><ArticleId IdType="pmc">PMC5898931</ArticleId><ArticleId IdType="pubmed">29563170</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwong J.C., Schwartz K.L., Campitelli M.A., Chung H., Crowcroft N.S., Karnauchow T., Katz K., Ko D.T., McGeer A.J., McNally D., et al. Acute myocardial infarction after laboratory-confirmed influenza infection. N. Engl. J. Med. 2018;378:345–353. doi: 10.1056/NEJMoa1702090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1702090</ArticleId><ArticleId IdType="pubmed">29365305</ArticleId></ArticleIdList></Reference><Reference><Citation>Davidson J.A., Warren-Gash C. Cardiovascular complications of acute respiratory infections: Current research and future directions. Expert Rev. Anti Infect. Ther. 2019;17:939–942. doi: 10.1080/14787210.2019.1689817.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14787210.2019.1689817</ArticleId><ArticleId IdType="pubmed">31684779</ArticleId></ArticleIdList></Reference><Reference><Citation>Gropper M.A., Wiener-Kronish J. The epithelium in acute lung injury/acute respiratory distress syndrome. Curr. Opin. Crit. Care. 2008;14:11–15. doi: 10.1097/MCC.0b013e3282f417a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MCC.0b013e3282f417a0</ArticleId><ArticleId IdType="pubmed">18195620</ArticleId></ArticleIdList></Reference><Reference><Citation>Caldeira D., Nogueira-Garcia B. Myocardial infarction and viral triggers: What do we know by now? Eur. Heart J. Suppl. 2023;25((Suppl. A)):A12–A16. doi: 10.1093/eurheartjsupp/suac122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartjsupp/suac122</ArticleId><ArticleId IdType="pmc">PMC10021489</ArticleId><ArticleId IdType="pubmed">36937373</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins S. Excess mortality from causes other than influenza and pneumonia during influenza epidemics. Public Health Rep. 1932;47:2159–2189. doi: 10.2307/4580606.</Citation><ArticleIdList><ArticleId IdType="doi">10.2307/4580606</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Meier C.R., Jick S.S., Derby L.E., Vasilakis C., Jick H. Acute respiratory-tract infections and risk of first-time acute myocardial infarction. Lancet. 1998;351:1467–1471. doi: 10.1016/S0140-6736(97)11084-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(97)11084-4</ArticleId><ArticleId IdType="pubmed">9605802</ArticleId></ArticleIdList></Reference><Reference><Citation>Clayton T.C., Capps N.E., Stephens N.G., Wedzicha J.A., Meade T.W. Recent respiratory infection and the risk of myocardial infarction. Heart. 2005;91:1601–1602. doi: 10.1136/hrt.2004.046920.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/hrt.2004.046920</ArticleId><ArticleId IdType="pmc">PMC1769237</ArticleId><ArticleId IdType="pubmed">16287745</ArticleId></ArticleIdList></Reference><Reference><Citation>Clayton T.C., Thompson M., Meade T.W. Recent respiratory infection and risk of cardiovascular disease: Case-control study through a general practice database. Eur. Heart J. 2008;29:96–103. doi: 10.1093/eurheartj/ehm516.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehm516</ArticleId><ArticleId IdType="pubmed">18063596</ArticleId></ArticleIdList></Reference><Reference><Citation>Veizades S., Tso A., Nguyen P.K. Infection, inflammation and thrombosis: A review of potential mechanisms mediating arterial thrombosis associated with influenza and severe acute respiratory syndrome coronavirus 2. Biol Chem. 2021;403:231–241. doi: 10.1515/hsz-2021-0348.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/hsz-2021-0348</ArticleId><ArticleId IdType="pubmed">34957734</ArticleId></ArticleIdList></Reference><Reference><Citation>Smeeth L., Thomas S.L., Hall A.J., Hubbard R., Farrington P., Vallance P. Risk of myocardial infarction and stroke after acute infection or vaccination. N. Engl. J. Med. 2004;351:2611–2618. doi: 10.1056/NEJMoa041747.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa041747</ArticleId><ArticleId IdType="pubmed">15602021</ArticleId></ArticleIdList></Reference><Reference><Citation>Musher D.M., Alexandraki I., Graviss E.A., Yanbeiy N., Eid A., Inderias L.A., Phan H.M., Solomon E. Bacteremic and nonbacteremic pneumococcal pneumonia. A prospective study. Medicine. 2000;79:210–221. doi: 10.1097/00005792-200007000-00002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005792-200007000-00002</ArticleId><ArticleId IdType="pubmed">10941350</ArticleId></ArticleIdList></Reference><Reference><Citation>Musher D.M., Rueda A.M., Kaka A.S., Mapara S.M. The association between pneumococcal pneumonia and acute cardiac events. Clin. Infect. Dis. 2007;45:158–165. doi: 10.1086/518849.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/518849</ArticleId><ArticleId IdType="pubmed">17578773</ArticleId></ArticleIdList></Reference><Reference><Citation>Pieralli F., Vannucchi V., Nozzoli C., Augello G., Dentali F., De Marzi G., Uomo G., Risaliti F., Morbidoni L., Mazzone A., et al. Acute cardiovascular events in patients with community acquired pneumonia: Results from the observational prospective FADOI-ICECAP study. BMC Infect Dis. 2021;21:116. doi: 10.1186/s12879-021-05781-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-021-05781-w</ArticleId><ArticleId IdType="pmc">PMC7830042</ArticleId><ArticleId IdType="pubmed">33494707</ArticleId></ArticleIdList></Reference><Reference><Citation>Africano H.F., Serrano-Mayorga C.C., Ramirez-Valbuena P.C., Bustos I.G., Bastidas A., Vargas H.A., Gómez S., Rodriguez A., Orihuela C.J., Reyes L.F. Major Adverse Cardiovascular Events During Invasive Pneumococcal Disease Are Serotype Dependent. Clin. Infect. Dis. 2021;72:e711–e719. doi: 10.1093/cid/ciaa1427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1427</ArticleId><ArticleId IdType="pmc">PMC8599727</ArticleId><ArticleId IdType="pubmed">32964223</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan X.R., Jiang L.X., Ma X.H. Relationship between Mycoplasma pneumoniae infection and acute myocardial infarction. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2008;20:236–237. (In Chinese)</Citation><ArticleIdList><ArticleId IdType="pubmed">18419961</ArticleId></ArticleIdList></Reference><Reference><Citation>Momiyama Y., Ohmori R., Taniguchi H., Nakamura H., Ohsuzu F. Association of Mycoplasma pneumoniae infection with coronary artery disease and its interaction with chlamydial infection. Atherosclerosis. 2004;176:139–144. doi: 10.1016/j.atherosclerosis.2004.04.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.atherosclerosis.2004.04.019</ArticleId><ArticleId IdType="pubmed">15306186</ArticleId></ArticleIdList></Reference><Reference><Citation>Long B., Brady W.J., Koyfman A., Gottlieb M. Cardiovascular complications in COVID-19. Am. J. Emerg. Med. 2020;38:1504–1507. doi: 10.1016/j.ajem.2020.04.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2020.04.048</ArticleId><ArticleId IdType="pmc">PMC7165109</ArticleId><ArticleId IdType="pubmed">32317203</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Prete A., Conway F., Della Rocca D.G., Biondi-Zoccai G., De Felice F., Musto C., Picichè M., Martuscelli E., Natale A., Versaci F. COVID-19, Acute Myocardial Injury, and Infarction. Card. Electrophysiol. Clin. 2022;14:29–39. doi: 10.1016/j.ccep.2021.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccep.2021.10.004</ArticleId><ArticleId IdType="pmc">PMC8556597</ArticleId><ArticleId IdType="pubmed">35221083</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S., Hu M., Zhang R., Xu J., Hou H., Wang Y., Yang H. The association between myocardial infarction and COVID-19 related mortality: A meta-analysis based on adjusted effect estimates. Am. J. Emerg. Med. 2022;57:227–229. doi: 10.1016/j.ajem.2022.02.050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2022.02.050</ArticleId><ArticleId IdType="pmc">PMC8883726</ArticleId><ArticleId IdType="pubmed">35272903</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuin M., Rigatelli G., Battisti V., Costola G., Roncon L., Bilato C. Increased risk of acute myocardial infarction after COVID-19 recovery: A systematic review and meta-analysis. Int. J. Cardiol. 2023;372:138–143. doi: 10.1016/j.ijcard.2022.12.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2022.12.032</ArticleId><ArticleId IdType="pmc">PMC9755219</ArticleId><ArticleId IdType="pubmed">36535564</ArticleId></ArticleIdList></Reference><Reference><Citation>Piroth L., Cottenet J., Mariet A.-S., Bonniaud P., Blot M., Tubert-Bitter P., Quantin C. Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: A nationwide, population-based retrospective cohort study. Lancet Respir. Med. 2021;9:251–259. doi: 10.1016/S2213-2600(20)30527-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30527-0</ArticleId><ArticleId IdType="pmc">PMC7832247</ArticleId><ArticleId IdType="pubmed">33341155</ArticleId></ArticleIdList></Reference><Reference><Citation>Ward A., Sarraju A., Lee D., Bhasin K., Gad S., Beetel R., Chang S., Bonafede M., Rodriguez F., Dash R. COVID-19 is associated with higher risk of venous thrombosis, but not arterial thrombosis, compared with influenza: Insights from a large US cohort. PLoS ONE. 2022;17:e0261786. doi: 10.1371/journal.pone.0261786.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0261786</ArticleId><ArticleId IdType="pmc">PMC8754296</ArticleId><ArticleId IdType="pubmed">35020742</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller E.C., Elkind M.S. Infection and Stroke: An Update on Recent Progress. Curr. Neurol. Neurosci. Rep. 2016;16:2. doi: 10.1007/s11910-015-0602-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11910-015-0602-9</ArticleId><ArticleId IdType="pmc">PMC6440211</ArticleId><ArticleId IdType="pubmed">26677196</ArticleId></ArticleIdList></Reference><Reference><Citation>Cornet M.C., Grose C., Vexler Z., Wu Y.W., Fullerton H.J. The Role of Infection and Inflammation in the Pathogenesis of Pediatric Arterial Ischemic Stroke. Semin. Pediatr. Neurol. 2022;44:100995. doi: 10.1016/j.spen.2022.100995.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.spen.2022.100995</ArticleId><ArticleId IdType="pubmed">36456035</ArticleId></ArticleIdList></Reference><Reference><Citation>Zurrú M.C., Alonzo C., Brescacín L., Romano M., Cámera L.A., Waisman G., Cristiano E., Ovbiagele B. Recent respiratory infection predicts atherothrombotic stroke: Case-control study in a Buenos Aires healthcare system. Stroke. 2009;40:1986–1990. doi: 10.1161/STROKEAHA.108.535559.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.108.535559</ArticleId><ArticleId IdType="pubmed">19359651</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L.F., Chen H.P., Huang Y.S., Huang K.Y., Chou P., Lee C.C. Pneumococcal pneumonia and the risk of stroke: A population-based follow-up study. PLoS ONE. 2012;7:e51452. doi: 10.1371/journal.pone.0051452.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0051452</ArticleId><ArticleId IdType="pmc">PMC3520842</ArticleId><ArticleId IdType="pubmed">23251538</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiang C.-H., Huang C.-C., Chan W.-L., Chen Y.-C., Chen T.-J., Lin S.-J., Chen J.-W., Leu H.-B. Association between Mycoplasma pneumonia and increased risk of ischemic stroke: A nationwide study. Stroke. 2011;42:2940–2943. doi: 10.1161/STROKEAHA.110.608075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.110.608075</ArticleId><ArticleId IdType="pubmed">21799166</ArticleId></ArticleIdList></Reference><Reference><Citation>Boehme A.K., Luna J., Kulick E.R., Kamel H., Elkind M.S.V. Influenza-like illness as a trigger for ischemic stroke. Ann. Clin. Transl. Neurol. 2018;5:456–463. doi: 10.1002/acn3.545.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.545</ArticleId><ArticleId IdType="pmc">PMC5899905</ArticleId><ArticleId IdType="pubmed">29687022</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo W., Liu X., Bao K., Huang C. Ischemic stroke associated with COVID-19: A systematic review and meta-analysis. J. Neurol. 2022;269:1731–1740. doi: 10.1007/s00415-021-10837-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10837-7</ArticleId><ArticleId IdType="pmc">PMC8517946</ArticleId><ArticleId IdType="pubmed">34652503</ArticleId></ArticleIdList></Reference><Reference><Citation>Babkina A.S., Yadgarov M.Y., Lyubomudrov M.A., Ostrova I.V., Volkov A.V., Kuzovlev A.N., Grechko A.V., Golubev A.M. Morphologic Findings in the Cerebral Cortex in COVID-19: Association of Microglial Changes with Clinical and Demographic Variables. Biomedicines. 2023;11:1407. doi: 10.3390/biomedicines11051407.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines11051407</ArticleId><ArticleId IdType="pmc">PMC10216380</ArticleId><ArticleId IdType="pubmed">37239078</ArticleId></ArticleIdList></Reference><Reference><Citation>Beach T.G., Sue L.I., Intorcia A.J., Glass M.J., Walker J.E., Arce R., Nelson C.M., Serrano G.E. Acute Brain Ischemia, Infarction and Hemorrhage in Subjects Dying with or without Autopsy-Proven Acute Pneumonia. medRxiv. 2021 doi: 10.1101/2021.03.22.21254139. medRxiv:2021.03.22.21254139.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.03.22.21254139</ArticleId></ArticleIdList></Reference><Reference><Citation>Merkler A.E., Parikh N.S., Mir S., Gupta A., Kamel H., Lin E., Lantos J., Schenck E.J., Goyal P., Bruce S.S., et al. Risk of Ischemic Stroke in Patients with Coronavirus Disease 2019 (COVID-19) vs Patients with Influenza. JAMA Neurol. 2020;77:1366–1372. doi: 10.1001/jamaneurol.2020.2730.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.2730</ArticleId><ArticleId IdType="pmc">PMC7333175</ArticleId><ArticleId IdType="pubmed">32614385</ArticleId></ArticleIdList></Reference><Reference><Citation>Smeeth L., Cook C., Thomas S., Hall A.J., Hubbard R., Vallance P. Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting. Lancet. 2006;367:1075–1079. doi: 10.1016/S0140-6736(06)68474-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(06)68474-2</ArticleId><ArticleId IdType="pubmed">16581406</ArticleId></ArticleIdList></Reference><Reference><Citation>Clayton T.C., Gaskin M., Meade T.W. Recent respiratory infection and risk of venous thromboembolism: Case-control study through a general practice database. Int. J. Epidemiol. 2011;40:819–827. doi: 10.1093/ije/dyr012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyr012</ArticleId><ArticleId IdType="pmc">PMC3147071</ArticleId><ArticleId IdType="pubmed">21324940</ArticleId></ArticleIdList></Reference><Reference><Citation>Ribeiro D.D., Lijfering W.M., Van Hylckama Vlieg A., Rosendaal F.R., Cannegieter S.C. Pneumonia and risk of venous thrombosis: Results from the MEGA study. J. Thromb. Haemost. 2012;10:1179–1182. doi: 10.1111/j.1538-7836.2012.04732.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-7836.2012.04732.x</ArticleId><ArticleId IdType="pubmed">22487204</ArticleId></ArticleIdList></Reference><Reference><Citation>Cattaneo M., Bertinato E.M., Birocchi S., Brizio C., Malavolta D., Manzoni M., Muscarella G., Orlandi M. Pulmonary embolism or pulmonary thrombosis in COVID-19? Is the recommendation to use high-dose heparin for thromboprophylaxis justified? Thromb. Haemost. 2020;120:1230–1232. doi: 10.1055/s-0040-1712097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0040-1712097</ArticleId><ArticleId IdType="pmc">PMC7516356</ArticleId><ArticleId IdType="pubmed">32349132</ArticleId></ArticleIdList></Reference><Reference><Citation>Birocchi S., Manzoni M., Podda G.M., Casazza G., Cattaneo M. High rates of pulmonary artery occlusions in COVID-19. A meta-analysis. Eur. J. Clin. Investig. 2021;51:e13433. doi: 10.1111/eci.13433.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/eci.13433</ArticleId><ArticleId IdType="pmc">PMC7646003</ArticleId><ArticleId IdType="pubmed">33053206</ArticleId></ArticleIdList></Reference><Reference><Citation>Poissy J., Goutay J., Caplan M., Parmentier E., Duburcq T., Lassalle F., Jeanpierre E., Rauch A., Labreuche J., Susen S. Pulmonary Embolism in Patients With COVID-19: Awareness of an Increased Prevalence. Circulation. 2020;142:184–186. doi: 10.1161/CIRCULATIONAHA.120.047430.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.047430</ArticleId><ArticleId IdType="pubmed">32330083</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao Y., Geng C., Li Y., Zhang Y. In situ Pulmonary Artery Thrombosis: A Previously Overlooked Disease. Front. Pharmacol. 2021;8:671589. doi: 10.3389/fphar.2021.671589.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.671589</ArticleId><ArticleId IdType="pmc">PMC8296465</ArticleId><ArticleId IdType="pubmed">34305592</ArticleId></ArticleIdList></Reference><Reference><Citation>Porembskaya O., Toropova Y., Tomson V., Lobastov K., Laberko L., Kravchuk V., Saiganov S., Brill A. Pulmonary Artery Thrombosis: A Diagnosis That Strives for Its Independence. Int. J. Mol. Sci. 2020;21:5086. doi: 10.3390/ijms21145086.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21145086</ArticleId><ArticleId IdType="pmc">PMC7404175</ArticleId><ArticleId IdType="pubmed">32708482</ArticleId></ArticleIdList></Reference><Reference><Citation>Benns M., Reilly P., Kim P. Early Pulmonary Embolism after Injury: A Different Clinical Entity? Injury. 2014;45:241–244. doi: 10.1016/j.injury.2013.02.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.injury.2013.02.026</ArticleId><ArticleId IdType="pubmed">23518042</ArticleId></ArticleIdList></Reference><Reference><Citation>Paffrath T., Wafaisade A., Lefering R., Simanski C., Bouillon B., Spanholtz T., Wutzler S., Maegele M. Trauma Registry of DGU Venous Thromboembolism after Severe Trauma: Incidence, Risk Factors and Outcome. Injury. 2010;41:97–101. doi: 10.1016/j.injury.2009.06.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.injury.2009.06.010</ArticleId><ArticleId IdType="pubmed">19608183</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Lange-Velde K., Srámek A., Vincken P.W., van Rooden J.K., Rosendaal F.R., Cannegieter S.C. Finding the origin of pulmonary emboli with a total-body magnetic resonance direct thrombus imaging technique. Haematologica. 2013;98:309–315. doi: 10.3324/haematol.2012.069195.</Citation><ArticleIdList><ArticleId IdType="doi">10.3324/haematol.2012.069195</ArticleId><ArticleId IdType="pmc">PMC3561441</ArticleId><ArticleId IdType="pubmed">22801962</ArticleId></ArticleIdList></Reference><Reference><Citation>Desborough M.J.R., Doyle A.J., Griffiths A., Retter A., Breen K.A., Hunt B.J. Image-proven thromboembolism in patients with severe COVID-19 in a tertiary critical care unit in the United Kingdom. Thromb. Res. 2020;193:1–4. doi: 10.1016/j.thromres.2020.05.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2020.05.049</ArticleId><ArticleId IdType="pmc">PMC7256551</ArticleId><ArticleId IdType="pubmed">32485437</ArticleId></ArticleIdList></Reference><Reference><Citation>Frantzeskaki F., Armaganidis A., Orfanos S.E. Immunothrombosis in Acute Respiratory Distress Syndrome: Cross Talks between Inflammation and Coagulation. Respiration. 2017;93:212–225. doi: 10.1159/000453002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000453002</ArticleId><ArticleId IdType="pubmed">27997925</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng K.H.L., Wu A.K.L., Cheng V.C.C., Tang B.S.F., Chan C.Y., Yung C.Y., Luk S.H., Lee T.W., Chow L., Yuen K.Y. Pulmonary artery thrombosis in a patient with severe acute respiratory syndrome. Postgrad. Med. J. 2005;81:e3. doi: 10.1136/pgmj.2004.030049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/pgmj.2004.030049</ArticleId><ArticleId IdType="pmc">PMC1743280</ArticleId><ArticleId IdType="pubmed">15937197</ArticleId></ArticleIdList></Reference><Reference><Citation>Harms P.W., Schmidt L.A., Smith L.B., Newton D.W., Pletneva M.A., Walters L.L., Tomlins S.A., Fisher-Hubbard A., Napolitano L.M., Park P.K., et al. Autopsy findings in eight patients with fatal H1N1 influenza. Am. J. Clin. Pathol. 2010;1:27–35. doi: 10.1309/AJCP35KOZSAVNQZW.</Citation><ArticleIdList><ArticleId IdType="doi">10.1309/AJCP35KOZSAVNQZW</ArticleId><ArticleId IdType="pubmed">20551263</ArticleId></ArticleIdList></Reference><Reference><Citation>Masana M., Martinez L.I., Gil M., Bueno G., Llagostera S. Thoracic Aortic Mural Thrombus, Right Ventricular Clot and Pulmonary Embolism in a Patient With COVID-19 Pneumonia. Vasc. Endovasc. Surg. 2021;55:273–276. doi: 10.1177/1538574420966106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1538574420966106</ArticleId><ArticleId IdType="pubmed">33034240</ArticleId></ArticleIdList></Reference><Reference><Citation>Sethi S.S., Zilinyi R., Green P., Eisenberger A., Brodie D., Agerstrand C., Takeda K., Kirtane A.J., Parikh S.A., Rosenzweig E.B. Right Ventricular Clot in Transit in COVID-19: Implications for the Pulmonary Embolism Response Team. JACC Case Rep. 2020;2:1391–1396. doi: 10.1016/j.jaccas.2020.05.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaccas.2020.05.034</ArticleId><ArticleId IdType="pmc">PMC7259913</ArticleId><ArticleId IdType="pubmed">32835284</ArticleId></ArticleIdList></Reference><Reference><Citation>Kashi M., Jacquin A., Dakhil B., Zaimi R., Mahé E., Tella E., Bagan P. Severe arterial thrombosis associated with Covid-19 infection. Thromb. Res. 2020;192:75–77. doi: 10.1016/j.thromres.2020.05.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2020.05.025</ArticleId><ArticleId IdType="pmc">PMC7229939</ArticleId><ArticleId IdType="pubmed">32425264</ArticleId></ArticleIdList></Reference><Reference><Citation>Afari H., Tefera L., Rosovsky R.P. Case of right ventricular and aortic thrombi in a patient with severe COVID-19. BMJ Case Rep. 2021;14:e240745. doi: 10.1136/bcr-2020-240745.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2020-240745</ArticleId><ArticleId IdType="pmc">PMC8057564</ArticleId><ArticleId IdType="pubmed">33875503</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrov A., Romera J.P.D.G., Wilbring M., Alexiou K., Kappert U., Matschke K.E., Tugtekin S.-M. Aortic Thrombosis following COVID-19: A Systematic Review. Thorac. Cardiovasc. Surg. 2022;70:323–332. doi: 10.1055/s-0041-1740554.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0041-1740554</ArticleId><ArticleId IdType="pubmed">35108736</ArticleId></ArticleIdList></Reference><Reference><Citation>Spreadbury M., Gubberud E., Halvorsen H., Bjørkum J., Butter A. Multiple arterial thromboemboli after COVID-19. Multiple arterielle tromboembolier etter covid-19. Tidsskr. Nor. Laegeforen. 2021;141:0289. doi: 10.4045/tidsskr.21.0289.</Citation><ArticleIdList><ArticleId IdType="doi">10.4045/tidsskr.21.0289</ArticleId><ArticleId IdType="pubmed">34423945</ArticleId></ArticleIdList></Reference><Reference><Citation>Tinelli G., Minelli F., Sica S., Tshomba Y. Complete aortic thrombosis in SARS-CoV-2 infection. Eur. Heart J. 2021;42:2314. doi: 10.1093/eurheartj/ehab011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehab011</ArticleId><ArticleId IdType="pmc">PMC7928995</ArticleId><ArticleId IdType="pubmed">33496316</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagashima M., Higaki T., Satoh H., Nakano T. Cardiac thrombus associated with Mycoplasma pneumoniae infection. Interact. Cardiovasc. Thorac. Surg. 2010;11:849–851. doi: 10.1510/icvts.2010.242115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1510/icvts.2010.242115</ArticleId><ArticleId IdType="pubmed">20847069</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi K., Yano S., Shishido S., Tokushima T. Invasive pulmonary aspergillosis with thrombosis in the left atrium. Intern. Med. 2001;40:250–254. doi: 10.2169/internalmedicine.40.250.</Citation><ArticleIdList><ArticleId IdType="doi">10.2169/internalmedicine.40.250</ArticleId><ArticleId IdType="pubmed">11310494</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishiguro T., Matsuo K., Fujii S., Takayanagi N. Acute thrombotic vascular events complicating influenza-associated pneumonia. Respir. Med. Case Rep. 2019;28:100884. doi: 10.1016/j.rmcr.2019.100884.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmcr.2019.100884</ArticleId><ArticleId IdType="pmc">PMC6582236</ArticleId><ArticleId IdType="pubmed">31245274</ArticleId></ArticleIdList></Reference><Reference><Citation>Sousa C., Almeida P., Gonçalves A., Rodrigues J., Rangel I., Macedo F., Maciel M.J. Large right ventricular thrombus. Acta Med. Port. 2014;27:390–393. doi: 10.20344/amp.4737.</Citation><ArticleIdList><ArticleId IdType="doi">10.20344/amp.4737</ArticleId><ArticleId IdType="pubmed">25017352</ArticleId></ArticleIdList></Reference><Reference><Citation>Segovia F.D., Ream S., Dang T., Chaganti B.T., Ortega A.J., Rhee S., Borges J.C. COVID-19-Associated Superior Mesenteric Artery Thrombosis and Acute Intestinal Ischemia. Cureus. 2022;14:e27722. doi: 10.7759/cureus.27722.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.27722</ArticleId><ArticleId IdType="pmc">PMC9441416</ArticleId><ArticleId IdType="pubmed">36081973</ArticleId></ArticleIdList></Reference><Reference><Citation>Carmo Filho A., Cunha B.D.S. Inferior mesenteric vein thrombosis and COVID-19. Rev. Soc. Bras. Med. Trop. 2020;53:e20200412. doi: 10.1590/0037-8682-0412-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/0037-8682-0412-2020</ArticleId><ArticleId IdType="pmc">PMC7508198</ArticleId><ArticleId IdType="pubmed">32965451</ArticleId></ArticleIdList></Reference><Reference><Citation>Gebran A., El Moheb M., Argandykov D., Mashbari H., Gartland R.M., Hwabejire J.O., Velmahos G.C., Kaafarani H.M. Mesenteric Ischemia in Patients with Coronavirus 2019: A Scoping Review. Surg. Infect. 2022;23:781–786. doi: 10.1089/sur.2022.154.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/sur.2022.154</ArticleId><ArticleId IdType="pubmed">36251963</ArticleId></ArticleIdList></Reference><Reference><Citation>Navarro-Martínez S., Diez Ares J.Á., Peris Tomás N., Gonzálvez Guardiola P., Pérez-Rubio Á. Superior mesenteric vein thrombosis as the only manifestation of SARS-CoV-2 infection. Cir. Esp. 2022;100:244–246. doi: 10.1016/j.ciresp.2021.03.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ciresp.2021.03.007</ArticleId><ArticleId IdType="pmc">PMC9008444</ArticleId><ArticleId IdType="pubmed">35431157</ArticleId></ArticleIdList></Reference><Reference><Citation>Sureshkumar N.B., Surendran S.A. Acute Mesenteric Ischemia in COVID-19 While Receiving Prophylactic Enoxaparin. Clin. Med. Res. 2022;20:236–240. doi: 10.3121/cmr.2022.1751.</Citation><ArticleIdList><ArticleId IdType="doi">10.3121/cmr.2022.1751</ArticleId><ArticleId IdType="pmc">PMC9799224</ArticleId><ArticleId IdType="pubmed">36581400</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins M.H., McGinn M.K., Weber D.J. Mesenteric Thrombosis Complicating Influenza B Infection. Am. J. Med. 2016;129:e17–e18. doi: 10.1016/j.amjmed.2016.01.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2016.01.019</ArticleId><ArticleId IdType="pubmed">26836382</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson M.L., Menjivar E., Kalapatapu V., Hand A.P., Garber J., Ruiz M.A. Mycoplasma pneumoniae associated with hemolytic anemia, cold agglutinins, and recurrent arterial thrombosis. South Med. J. 2007;100:215–217. doi: 10.1097/01.smj.0000254212.35432.99.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.smj.0000254212.35432.99</ArticleId><ArticleId IdType="pubmed">17330697</ArticleId></ArticleIdList></Reference><Reference><Citation>Bao X.L., Tang N., Wang Y.Z. Severe Klebsiella pneumoniae pneumonia complicated by acute intra-abdominal multiple arterial thrombosis and bacterial embolism: A case report. World J. Clin. Cases. 2022;10:11101–11110. doi: 10.12998/wjcc.v10.i30.11101.</Citation><ArticleIdList><ArticleId IdType="doi">10.12998/wjcc.v10.i30.11101</ArticleId><ArticleId IdType="pmc">PMC9631156</ArticleId><ArticleId IdType="pubmed">36338208</ArticleId></ArticleIdList></Reference><Reference><Citation>Fournier M., Faille D., Dossier A., Mageau A., Roland P.N., Ajzenberg N., Borie R., Bouadma L., Bunel V., Castier Y., et al. Arterial thrombotic events in adult inpatients with COVID-19. Mayo Clin. Proc. 2021;96:295–303. doi: 10.1016/j.mayocp.2020.11.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2020.11.018</ArticleId><ArticleId IdType="pmc">PMC7691140</ArticleId><ArticleId IdType="pubmed">33549252</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilaloglu S., Aphinyanaphongs Y., Jones S., Iturrate E., Hochman J., Berger J.S. Thrombosis in hospitalized patients with COVID-19 in a New York City health system. JAMA. 2020;324:799–801. doi: 10.1001/jama.2020.13372.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.13372</ArticleId><ArticleId IdType="pmc">PMC7372509</ArticleId><ArticleId IdType="pubmed">32702090</ArticleId></ArticleIdList></Reference><Reference><Citation>Attisani L., Pucci A., Luoni G., Luzzani L., Pegorer M.A., Settembrini A.M., Bissacco D., Wohlauer M.V., Piffaretti G., Bellosta R. COVID-19 and acute limb ischemia: A systematic review. J. Cardiovasc. Surg. 2021;62:542–547. doi: 10.23736/S0021-9509.21.12017-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.23736/S0021-9509.21.12017-8</ArticleId><ArticleId IdType="pubmed">34581552</ArticleId></ArticleIdList></Reference><Reference><Citation>Sánchez J.B., Alcalde J.D.C., Isidro R.R., Luna C.Z., Cubas W.S., Charres A.C., Gutiérrez J.E., Ochoa J.D., Arias P.F. Acute limb ischemia in a Peruvian cohort infected by COVID-19. Ann. Vasc. Surg. 2021;72:196–204. doi: 10.1016/j.avsg.2020.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.avsg.2020.12.005</ArticleId><ArticleId IdType="pmc">PMC7836937</ArticleId><ArticleId IdType="pubmed">33388408</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson O., Pierce D., Whang D., O’Malley M., Geise B., Malhotra U. Acute limb ischemia as sole initial manifestation of SARS-CoV-2 infection. J. Vasc. Surg. Cases Innov. Tech. 2020;6:511–513. doi: 10.1016/j.jvscit.2020.07.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvscit.2020.07.017</ArticleId><ArticleId IdType="pmc">PMC7441972</ArticleId><ArticleId IdType="pubmed">32864520</ArticleId></ArticleIdList></Reference><Reference><Citation>Rinaldo J.E., Perez H. Ischemic necrosis of both lower extremities as a result of the microembolism syndrome complicating the adult respiratory distress syndrome caused by Escherichia coli pneumonia and septicemia. Am. Rev. Respir. Dis. 1982;126:932–935. doi: 10.1164/arrd.1982.126.5.932.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/arrd.1982.126.5.932</ArticleId><ArticleId IdType="pubmed">6756235</ArticleId></ArticleIdList></Reference><Reference><Citation>Joo C.U., Kim J.S., Han Y.M. Mycoplasma pneumoniae induced popliteal artery thrombosis treated with urokinase. Postgrad. Med. J. 2001;77:723–724. doi: 10.1136/pmj.77.913.723.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/pmj.77.913.723</ArticleId><ArticleId IdType="pmc">PMC1742178</ArticleId><ArticleId IdType="pubmed">11677283</ArticleId></ArticleIdList></Reference><Reference><Citation>Ducloux G., Defaux D., Folliot J.P., Laurent J.M. Thrombose artérielle fémorale en rapport avec une infection à Mycoplasma pneumoniae [Femoral artery thrombosis associated with Mycoplasma pneumoniae infection] LARC Med. 1981;1:42–44.</Citation><ArticleIdList><ArticleId IdType="pubmed">7052238</ArticleId></ArticleIdList></Reference><Reference><Citation>Peyton B.D., Cutler B.S., Stewart F.M. Spontaneous tibial artery thrombosis associated with varicella pneumonia and free protein S deficiency. J. Vasc. Surg. 1998;27:563–567. doi: 10.1016/S0741-5214(98)70335-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0741-5214(98)70335-0</ArticleId><ArticleId IdType="pubmed">9546247</ArticleId></ArticleIdList></Reference><Reference><Citation>Paparoupa M., Spineli L., Framke T., Ho H., Schuppert F., Gillissen A. Pulmonary Embolism in Pneumonia: Still a Diagnostic Challenge? Results of a Case-Control Study in 100 Patients. Dis. Markers. 2016;2016:8682506. doi: 10.1155/2016/8682506.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2016/8682506</ArticleId><ArticleId IdType="pmc">PMC4897677</ArticleId><ArticleId IdType="pubmed">27313336</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanelin J., Eyler W.R. Pulmonary artery thrombosis; roentgen manifestations. Radiology. 1951;5:689–703. doi: 10.1148/56.5.689.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/56.5.689</ArticleId><ArticleId IdType="pubmed">14844680</ArticleId></ArticleIdList></Reference><Reference><Citation>Baranga L., Khanuja S., Scott J.A., Provancha I., Gosselin M., Walsh J., Arancibia R., Bruno M.A., Waite S. In Situ Pulmonary Arterial Thrombosis: Literature Review and Clinical Significance of a Distinct Entity. AJR Am. J. Roentgenol. 2023;1:57–68. doi: 10.2214/AJR.23.28996.</Citation><ArticleIdList><ArticleId IdType="doi">10.2214/AJR.23.28996</ArticleId><ArticleId IdType="pubmed">36856299</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Gal G., Righini M., Parent F., van Strijen M., Couturaud F. Diagnosis and management of subsegmental pulmonary embolism. J. Thromb. Haemost. 2006;4:724–731. doi: 10.1111/j.1538-7836.2006.01819.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-7836.2006.01819.x</ArticleId><ArticleId IdType="pubmed">16634736</ArticleId></ArticleIdList></Reference><Reference><Citation>Trunz L.M., Lee P., Lange S.M., Pomeranz C.L., Needleman L., Ford R.W., Karambelkar A., Sundaram B. Imaging approach to COVID-19 associated pulmonary embolism. Int. J. Clin. Pract. 2021;75:e14340. doi: 10.1111/ijcp.14340.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.14340</ArticleId><ArticleId IdType="pmc">PMC8237008</ArticleId><ArticleId IdType="pubmed">33966326</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang C., Xu L. Chlamydia psittaci Pneumonia-Induced Pulmonary Thrombosis: A Case Report. Infect. Drug Resist. 2023;16:7063–7069. doi: 10.2147/IDR.S435246.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IDR.S435246</ArticleId><ArticleId IdType="pmc">PMC10637264</ArticleId><ArticleId IdType="pubmed">37954503</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaudhary R., Kreutz R.P., Bliden K.P., Tantry U.S., Gurbel P.A. Personalizing Antithrombotic Therapy in COVID-19: Role of Thromboelastography and Thromboelastometry. Thromb Haemost. 2020;120:1594–1596. doi: 10.1055/s-0040-1714217.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0040-1714217</ArticleId><ArticleId IdType="pubmed">32679595</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Qutob D., Alvarez-Arroyo L., Barreda I., Nieto M., Pin M., Poveda-Andrés J.L., Carrera-Hueso F.J. High incidence of pulmonary thromboembolism in hospitalized SARS-CoV-2 infected patients despite thrombo-prophylaxis. Heart Lung. 2022;53:77–82. doi: 10.1016/j.hrtlng.2022.02.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrtlng.2022.02.003</ArticleId><ArticleId IdType="pmc">PMC8823955</ArticleId><ArticleId IdType="pubmed">35180507</ArticleId></ArticleIdList></Reference><Reference><Citation>Ge Y., Liu C., Wang N., Xu J., Zhu X., Su C., Li H., Zhang H., Li Z., Li H., et al. Elevated Plasma D-Dimer in Adult Community-Acquired Pneumonia Patients is Associated with an Increased Inflammatory Reaction and Lower Survival. Clin. Lab. 2019;65:180720. doi: 10.7754/Clin.Lab.2018.180720.</Citation><ArticleIdList><ArticleId IdType="doi">10.7754/Clin.Lab.2018.180720</ArticleId><ArticleId IdType="pubmed">30775898</ArticleId></ArticleIdList></Reference><Reference><Citation>Crowther M.A., Cook D.J., Griffith L.E., Devereaux P.J., Rabbat C.C., Clarke F.J., Hoad N., McDonald E., Meade M.O., Guyatt G.H., et al. Deep venous thrombosis: Clinically silent in the intensive care unit. J. Crit. Care. 2005;20:334–340. doi: 10.1016/j.jcrc.2005.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2005.09.011</ArticleId><ArticleId IdType="pubmed">16310604</ArticleId></ArticleIdList></Reference><Reference><Citation>Umairi R.A., Adawi K.A., Khoori M.A., Lawati A.A., Jose S. COVID-19-Associated Thrombotic Complication: Is It Pulmonary Embolism or In Situ Thrombosis? Radiol. Res. Pract. 2023;2023:3844069. doi: 10.1155/2023/3844069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2023/3844069</ArticleId><ArticleId IdType="pmc">PMC10332914</ArticleId><ArticleId IdType="pubmed">37435092</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Dam L., Kroft L., van der Wal L., Cannegieter S., Eikenboom J., de Jonge E., Huisman M., Klok F. Clinical and computed tomography characteristics of COVID-19 associated acute pulmonary embolism: A different phenotype of thrombotic disease? Thromb. Res. 2020;193:86–89. doi: 10.1016/j.thromres.2020.06.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2020.06.010</ArticleId><ArticleId IdType="pmc">PMC7274953</ArticleId><ArticleId IdType="pubmed">32531548</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z.B., Xie W.M., Zhai Z.G., Cao B., Wan J. Pulmonary aspergillosis with in-situ pulmonary artery thrombosis: To anti-coagulate or not? Chin. Med. J. 2019;14:1742–1744. doi: 10.1097/CM9.0000000000000336.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CM9.0000000000000336</ArticleId><ArticleId IdType="pmc">PMC6759103</ArticleId><ArticleId IdType="pubmed">31268912</ArticleId></ArticleIdList></Reference><Reference><Citation>Emad Y., Ragab Y., Farber H.W., Erkan D., Ibrahim O., Kindermann M., Tekavec-Trkanjec J., Jayakrishnan B., El-Shaarawy N., Rasker J.J., et al. Pulmonary embolism versus pulmonary vasculitis in Hughes-Stovin syndrome: Characteristic computed tomography pulmonary angiographic findings and diagnostic and therapeutic implications. HSS International Study Group. Thromb. Res. 2024;239:109040. doi: 10.1016/j.thromres.2024.109040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2024.109040</ArticleId><ArticleId IdType="pubmed">38795561</ArticleId></ArticleIdList></Reference><Reference><Citation>Katz D.S., Loud P.A., Bruce D., Gittleman A.M., Mueller R., Klippenstein D.L., Grossman Z.D. Combined CT venography and pulmonary angiography: A comprehensive review. Radiographics. 2002;22:S3–S24. doi: 10.1148/radiographics.22.suppl_1.g02oc17s3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiographics.22.suppl_1.g02oc17s3</ArticleId><ArticleId IdType="pubmed">12376597</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker J.A., Coleman R.E., Grady E., Royal H.D., Siegel B.A., Stabin M.G., Sostman H.D., Hilson A.J., Society of Nuclear Medicine SNM practice guideline for lung scintigraphy 4.0. J. Nucl. Med. Technol. 2012;1:57–65. doi: 10.2967/jnmt.111.101386.</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnmt.111.101386</ArticleId><ArticleId IdType="pubmed">22282651</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore A.J.E., Wachsmann J., Chamarthy M.R., Panjikaran L., Tanabe Y., Rajiah P. Imaging of acute pulmonary embolism: An update. Cardiovasc. Diagn. Ther. 2018;3:225–243. doi: 10.21037/cdt.2017.12.01.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/cdt.2017.12.01</ArticleId><ArticleId IdType="pmc">PMC6039809</ArticleId><ArticleId IdType="pubmed">30057872</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson D.R., Barnes D.C. Computerized tomographic pulmonary angiography versus ventilation perfusion lung scanning for the diagnosis of pulmonary embolism. Curr. Opin. Pulm. Med. 2009;5:425–429. doi: 10.1097/MCP.0b013e32832d6b98.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MCP.0b013e32832d6b98</ArticleId><ArticleId IdType="pubmed">19465853</ArticleId></ArticleIdList></Reference><Reference><Citation>Bang J.I., Lee W.W., Cho S.G., Choi M., Song Y.S. The Diagnostic Accuracy of SPECT Imaging in Patients with Suspected Pulmonary Embolism: Systematic Review and Network Meta-analysis. Clin. Nucl. Med. 2024;7:637–643. doi: 10.1097/RLU.0000000000005167.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/RLU.0000000000005167</ArticleId><ArticleId IdType="pubmed">38831512</ArticleId></ArticleIdList></Reference><Reference><Citation>Yilmaz F., Tunçez A., Önner H., Gedik G.K., Uysal E., Körez M.K. Diagnostic compatibility of V/Q SPECT and CTPA, which are non-invasive diagnostic methods, for the detection of CTEPH, which is a treatable cause of pulmonary hypertension. Hell J. Nucl. Med. 2022;2:168–176. doi: 10.1967/s002449912478.</Citation><ArticleIdList><ArticleId IdType="doi">10.1967/s002449912478</ArticleId><ArticleId IdType="pubmed">35913865</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson D.R., Kahn S.R., Rodger M.A., Kovacs M.J., Morris T., Hirsch A., Lang E., Stiell I., Kovacs G., Dreyer J., et al. Computed tomographic pulmonary angiography vs ventilation-perfusion lung scanning in patients with suspected pulmonary embolism: A randomized controlled trial. JAMA. 2007;23:2743–2753. doi: 10.1001/jama.298.23.2743.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.298.23.2743</ArticleId><ArticleId IdType="pubmed">18165667</ArticleId></ArticleIdList></Reference><Reference><Citation>Tessonnier L., Guedj E., Cano A., Cammilleri S., Dragulescu A., Chabrol B., Mundler O. Multiple distal pulmonary arterial thromboses revealed by lung scintigraphy in a patient with homocystinuria and normal multidetector CT pulmonary angiography. Clin. Nucl. Med. 2009;34:42–43. doi: 10.1097/RLU.0b013e31818f459a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/RLU.0b013e31818f459a</ArticleId><ArticleId IdType="pubmed">19092386</ArticleId></ArticleIdList></Reference><Reference><Citation>De Bruyn V.H., Bergmann R., Keyt B.A., Bennett W.F., Sobel B.E. Scintigraphic visualization of pulmonary thrombi with 123I-YPACK-TNK-tPA. Coron. Artery Dis. 1995;9:715–721.</Citation><ArticleIdList><ArticleId IdType="pubmed">8747877</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim B., Yao Y., Huang A.L., Yap M.L., Flierl U., Palasubramaniam J., Zaldivia M.T.K., Wang X., Peter K. A Unique Recombinant Fluoroprobe Targeting Activated Platelets Allows In Vivo Detection of Arterial Thrombosis and Pulmonary Embolism Using a Novel Three-Dimensional Fluorescence Emission Computed Tomography (FLECT) Technology. Theranostics. 2017;5:1047–1061. doi: 10.7150/thno.18099.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.18099</ArticleId><ArticleId IdType="pmc">PMC5399575</ArticleId><ArticleId IdType="pubmed">28435447</ArticleId></ArticleIdList></Reference><Reference><Citation>Yende S., D’Angelo G., Mayr F., Kellum J.A., Weissfeld L., Kaynar A.M., Young T., Irani K., Angus D.C. Elevated hemostasis markers after pneumonia increases one-year risk of all-cause and cardiovascular deaths. PLoS ONE. 2011;6:e22847. doi: 10.1371/journal.pone.0022847.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0022847</ArticleId><ArticleId IdType="pmc">PMC3154260</ArticleId><ArticleId IdType="pubmed">21853050</ArticleId></ArticleIdList></Reference><Reference><Citation>Bone R.C., Francis P.B., Pierce A.K. Intravascular coagulation associated with the adult respiratory distress syndrome. Am. J. Med. 1976;61:585–589. doi: 10.1016/0002-9343(76)90135-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9343(76)90135-2</ArticleId><ArticleId IdType="pubmed">984062</ArticleId></ArticleIdList></Reference><Reference><Citation>Saldeen T. Intravascular coagulation in the lungs in experimental fat embolism. Acta Chir. Scand. 1969;135:653–662.</Citation><ArticleIdList><ArticleId IdType="pubmed">5368950</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang N., Li D., Wang X., Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J. Thromb. Haemost. 2020;4:844–847. doi: 10.1111/jth.14768.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14768</ArticleId><ArticleId IdType="pmc">PMC7166509</ArticleId><ArticleId IdType="pubmed">32073213</ArticleId></ArticleIdList></Reference><Reference><Citation>Spiezia L., Boscolo A., Poletto F. COVID-19-related severe hypercoagulability in patients admitted to intensive care unit for acute respiratory failure. Thromb. Haemost. 2020;6:998–1000. doi: 10.1055/s-0040-1710018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0040-1710018</ArticleId><ArticleId IdType="pmc">PMC7295272</ArticleId><ArticleId IdType="pubmed">32316063</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranucci M., Ballotta A., Di Dedda U. The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome. J. Thromb. Haemost. 2020;7:1747–1751. doi: 10.1111/jth.14854.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14854</ArticleId><ArticleId IdType="pmc">PMC9906332</ArticleId><ArticleId IdType="pubmed">32302448</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoechter D.J., Becker-Pennrich A., Langrehr J., Bruegel M., Zwissler B., Schaefer S., Spannagl M., Hinske L.C., Zoller M. Higher procoagulatory potential but lower DIC score in COVID-19 ARDS patients compared to non-COVID-19 ARDS patients. Thromb. Res. 2020;196:186–192. doi: 10.1016/j.thromres.2020.08.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2020.08.030</ArticleId><ArticleId IdType="pmc">PMC7441951</ArticleId><ArticleId IdType="pubmed">32891904</ArticleId></ArticleIdList></Reference><Reference><Citation>Spiezia L., Campello E., Cola M., Poletto F., Cerruti L., Poretto A., Simion C., Cattelan A., Vettor R., Simioni P. More Severe Hypercoagulable State in Acute COVID-19 Pneumonia as Compared with Other Pneumonia. Mayo Clin. Proc. Innov. Qual. Outcomes. 2020;6:696–702. doi: 10.1016/j.mayocpiqo.2020.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocpiqo.2020.09.002</ArticleId><ArticleId IdType="pmc">PMC7528900</ArticleId><ArticleId IdType="pubmed">33024937</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell W.B. Thromboinflammation in COVID-19 acute lung injury. Paediatr. Respir. Rev. 2020;35:20–24. doi: 10.1016/j.prrv.2020.06.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.prrv.2020.06.004</ArticleId><ArticleId IdType="pmc">PMC7289106</ArticleId><ArticleId IdType="pubmed">32653469</ArticleId></ArticleIdList></Reference><Reference><Citation>Ochoa C.D., Wu S., Stevens T. New developments in lung endothelial heterogeneity: Von Willebrand factor, P-selectin, and the Weibel-Palade body. Semin Thromb. Hemost. 2010;36:301–308. doi: 10.1055/s-0030-1253452.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0030-1253452</ArticleId><ArticleId IdType="pmc">PMC2917989</ArticleId><ArticleId IdType="pubmed">20490980</ArticleId></ArticleIdList></Reference><Reference><Citation>Libby P., Lüscher T. COVID-19 is, in the end, an endothelial disease. Eur. Heart J. 2020;41:3038–3044. doi: 10.1093/eurheartj/ehaa623.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa623</ArticleId><ArticleId IdType="pmc">PMC7470753</ArticleId><ArticleId IdType="pubmed">32882706</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubins J.B., Duane P.G., Charboneau D., Janoff E.N. Toxicity of pneumolysin to pulmonary endothelial cells in vitro. Infect Immun. 1992;60:1740–1746. doi: 10.1128/iai.60.5.1740-1746.1992.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/iai.60.5.1740-1746.1992</ArticleId><ArticleId IdType="pmc">PMC257067</ArticleId><ArticleId IdType="pubmed">1563759</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibson R.L., Soderland C., Henderson W.R., Jr., Chi E.Y., Rubens C.E. Group B streptococci (GBS) injure lung endothelium in vitro: GBS invasion and GBS-induced eicosanoid production is greater with microvascular than with pulmonary artery cells. Infect. Immun. 1995;63:271–279. doi: 10.1128/iai.63.1.271-279.1995.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/iai.63.1.271-279.1995</ArticleId><ArticleId IdType="pmc">PMC172988</ArticleId><ArticleId IdType="pubmed">7806366</ArticleId></ArticleIdList></Reference><Reference><Citation>Birkun A.A., Zagoruĺko A.K. Ultrastructural changes in the endothelium of lung capillaries during experimental pneumonia. Cor. Vasa. 1991;33:75–81.</Citation><ArticleIdList><ArticleId IdType="pubmed">1914469</ArticleId></ArticleIdList></Reference><Reference><Citation>Spadaro S., Fogagnolo A., Campo G., Zucchetti O., Verri M., Ottaviani I., Tunstall T., Grasso S., Scaramuzzo V., Murgolo F., et al. Markers of endothelial and epithelial pulmonary injury in mechanically ventilated COVID-19 ICU patients. Crit. Care. 2021;25:74. doi: 10.1186/s13054-021-03499-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-021-03499-4</ArticleId><ArticleId IdType="pmc">PMC7894238</ArticleId><ArticleId IdType="pubmed">33608030</ArticleId></ArticleIdList></Reference><Reference><Citation>Glas G.J., Van Der Sluijs K.F., Schultz M.J., Hofstra J.J., Van Der Poll T., Levi M. Bronchoalveolar hemostasis in lung injury and acute respiratory distress syndrome. J. Thromb. Haemost. 2013;11:17–25. doi: 10.1111/jth.12047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.12047</ArticleId><ArticleId IdType="pubmed">23114008</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryu K.H., Hindman B.J., Reasoner D.K., Dexter F. Heparin reduces neurological impairment after cerebral arterial air embolism in the rabbit. Stroke. 1996;27:303–310. doi: 10.1161/01.STR.27.2.303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.STR.27.2.303</ArticleId><ArticleId IdType="pubmed">8571428</ArticleId></ArticleIdList></Reference><Reference><Citation>Sims P.J., Wiedmer T. Induction of cellular procoagulant activity by the membrane attack complex of complement. Semin. Cell Biol. 1995;6:275–282. doi: 10.1006/scel.1995.0037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/scel.1995.0037</ArticleId><ArticleId IdType="pubmed">8562920</ArticleId></ArticleIdList></Reference><Reference><Citation>Keragala C.B., Draxler D.F., McQuilten Z.K., Medcalf R.L. Haemostasis and innate immunity—A complementary relationship: A review of the intricate relationship between coagulation and complement pathways. Br. J. Haematol. 2018;180:782–798. doi: 10.1111/bjh.15062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjh.15062</ArticleId><ArticleId IdType="pubmed">29265338</ArticleId></ArticleIdList></Reference><Reference><Citation>Lüscher E.F. Induction of platelet aggregation by immune complexes. Ser. Haematol. 1970;3:121–129.</Citation><ArticleIdList><ArticleId IdType="pubmed">4107202</ArticleId></ArticleIdList></Reference><Reference><Citation>Penny R., Castaldi P.A., Whitsed H.M. Inflammation and haemostasis in paraproteinaemias. Br. J. Haematol. 1971;20:35–44. doi: 10.1111/j.1365-2141.1971.tb00784.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2141.1971.tb00784.x</ArticleId><ArticleId IdType="pubmed">4924493</ArticleId></ArticleIdList></Reference><Reference><Citation>Lisiewicz J. Rola leukocytów w biomorfozie zakrzepów i krzepnieciu krwi [The role of leukocytes in the biomorphosis of thrombosis and blood coagulation] Acta Physiol. Pol. 1971;22:785–789.</Citation><ArticleIdList><ArticleId IdType="pubmed">5292643</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine P.H., Weinger R.S., Simon J., Scoon K.L., Krinsky N.I. Leukocyte-platelet interaction. Release of hydrogen peroxide by granulocytes as a modulator of platelet reactions. J. Clin. Investig. 1976;57:955–963. doi: 10.1172/JCI108372.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI108372</ArticleId><ArticleId IdType="pmc">PMC436739</ArticleId><ArticleId IdType="pubmed">947961</ArticleId></ArticleIdList></Reference><Reference><Citation>Eilertsen K.E., Østerud B. Tissue factor: (patho)physiology and cellular biology. Blood Coagul. Fibrinolysis. 2004;15:521–538. doi: 10.1097/00001721-200410000-00001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00001721-200410000-00001</ArticleId><ArticleId IdType="pubmed">15389118</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastarache J.A., Wang L., Geiser T., Wang Z., Albertine K.H., Matthay M.A., Ware L.B. The alveolar epithelium can initiate the extrinsic coagulation cascade through expression of tissue factor. Thorax. 2007;62:608–616. doi: 10.1136/thx.2006.063305.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thx.2006.063305</ArticleId><ArticleId IdType="pmc">PMC2117249</ArticleId><ArticleId IdType="pubmed">17356058</ArticleId></ArticleIdList></Reference><Reference><Citation>Levi M., van der Poll T., Schultz M. New insights into pathways that determine the link between infection and thrombosis. Neth. J. Med. 2012;70:114–120.</Citation><ArticleIdList><ArticleId IdType="pubmed">22516575</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastarache J.A., Fremont R.D., Kropski J.A., Bossert F.R., Ware L.B. Procoagulant alveolar microparticles in the lungs of patients with acute respiratory distress syndrome. Am. J. Physiol. Lung Cell Mol Physiol. 2009;297:L1035–L1041. doi: 10.1152/ajplung.00214.2009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00214.2009</ArticleId><ArticleId IdType="pmc">PMC2793184</ArticleId><ArticleId IdType="pubmed">19700643</ArticleId></ArticleIdList></Reference><Reference><Citation>Maris N., de Vos A., Bresser P., van der Zee J., Meijers J., Lijnen R., Levi M., Jansen H., van der Poll T. Activation of coagulation and inhibition of fibrinolysis in the lung after inhalation of lipopolysaccharide by healthy volunteers. Thromb. Haemost. 2005;93:1036–1040. doi: 10.1160/TH04-08-0492.</Citation><ArticleIdList><ArticleId IdType="doi">10.1160/TH04-08-0492</ArticleId><ArticleId IdType="pubmed">15968385</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoogerwerf J.J., de Vos A.F., Bresser P., van der Zee J.S., Pater J.M., de Boer A., Tanck M., Lundell D.L., Her-Jenh C., Draing C., et al. Lung inflammation induced by lipoteichoic acid or lipopolysaccharide in humans. Am. J. Respir. Crit. Care Med. 2008;178:34–41. doi: 10.1164/rccm.200708-1261OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.200708-1261OC</ArticleId><ArticleId IdType="pubmed">18403723</ArticleId></ArticleIdList></Reference><Reference><Citation>Aras O., Shet A., Bach R.R., Hysjulien J.L., Slungaard A., Hebbel R.P., Escolar G., Jilma B., Key N.S. Induction of microparticle- and cell-associated intravascular tissue factor in human endotoxemia. Blood. 2004;103:4545–4553. doi: 10.1182/blood-2003-03-0713.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2003-03-0713</ArticleId><ArticleId IdType="pubmed">14988149</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramaniam S., Kothari H., Bosmann M. Tissue factor in COVID-19-associated coagulopathy. Thromb. Res. 2022;220:35–47. doi: 10.1016/j.thromres.2022.09.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2022.09.025</ArticleId><ArticleId IdType="pmc">PMC9525243</ArticleId><ArticleId IdType="pubmed">36265412</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackman N., Grover S.P., Antoniak S. Tissue factor expression, extracellular vesicles, and thrombosis after infection with the respiratory viruses influenza A virus and coronavirus. J. Thromb. Haemost. 2021;19:2652–2658. doi: 10.1111/jth.15509.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15509</ArticleId><ArticleId IdType="pmc">PMC9770926</ArticleId><ArticleId IdType="pubmed">34418279</ArticleId></ArticleIdList></Reference><Reference><Citation>Rijneveld A.W., Weijer S., Bresser P., Florquin S., Vlasuk G.P., Rote W.E., Spek C.A., Reitsma P.H., van der Zee J.S., Levi M., et al. Local activation of the tissue factor-factor VIIa pathway in patients with pneumonia and the effect of inhibition of this pathway in murine pneumococcal pneumonia. Crit. Care Med. 2006;34:1725–1730. doi: 10.1097/01.CCM.0000218807.20570.C2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000218807.20570.C2</ArticleId><ArticleId IdType="pubmed">16625114</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller D.L., Welty-Wolf K., Carraway M.S., Ezban M., Ghio A., Suliman H., Piantadosi C.A. Extrinsic coagulation blockade attenuates lung injury and proinflammatory cytokine release after intratracheal lipopolysaccharide. Am. J. Respir. Cell Mol. Biol. 2002;26:650–658. doi: 10.1165/ajrcmb.26.6.4688.</Citation><ArticleIdList><ArticleId IdType="doi">10.1165/ajrcmb.26.6.4688</ArticleId><ArticleId IdType="pubmed">12034563</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y., Wang Y., Liu B., Erkan D., Ibrahim O., Kindermann M., Tekavec-Trkanjec J., Jayakrishnan B., El-Shaarawy N., Rasker J.J. SN50 attenuates alveolar hypercoagulation and fibrinolysis inhibition in acute respiratory distress syndrome mice through inhibiting NF-κB p65 translocation. Respir. Res. 2020;21:130. doi: 10.1186/s12931-020-01372-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-020-01372-6</ArticleId><ArticleId IdType="pmc">PMC7251840</ArticleId><ArticleId IdType="pubmed">32460750</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang H., Qian H., Liu B., Wu Y., Cheng Y., Zheng X., Li X., Yang G., He T., Li S., et al. Triptolide dose-dependently improves LPS-induced alveolar hypercoagulation and fibrinolysis inhibition through NF-κB inactivation in ARDS mice. Biomed. Pharmacother. 2021;139:111569. doi: 10.1016/j.biopha.2021.111569.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2021.111569</ArticleId><ArticleId IdType="pubmed">34243622</ArticleId></ArticleIdList></Reference><Reference><Citation>Antoniak S., Tatsumi K., Hisada Y., Milner J.J., Neidich S.D., Shaver C.M., Pawlinski R., Beck M.A., Bastarache J.A., Mackman N. Tissue factor deficiency increases alveolar hemorrhage and death in influenza A virus-infected mice. J. Thromb. Haemost. 2016;14:1238–1248. doi: 10.1111/jth.13307.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.13307</ArticleId><ArticleId IdType="pmc">PMC5892427</ArticleId><ArticleId IdType="pubmed">26947929</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin X., Duan Y., Bao T., Gu J., Chen Y., Li Y., Mao S., Chen Y., Xie W. The values of coagulation function in COVID-19 patients. PLoS ONE. 2020;15:e0241329. doi: 10.1371/journal.pone.0241329.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0241329</ArticleId><ArticleId IdType="pmc">PMC7595402</ArticleId><ArticleId IdType="pubmed">33119703</ArticleId></ArticleIdList></Reference><Reference><Citation>Okamoto H., Muraki I., Okada H., Tomita H., Suzuki K., Takada C., Wakayama Y., Kuroda A., Fukuda H., Kawasaki Y., et al. Recombinant Antithrombin Attenuates Acute Respiratory Distress Syndrome in Experimental Endotoxemia. Am. J. Pathol. 2021;191:1526–1536. doi: 10.1016/j.ajpath.2021.05.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2021.05.015</ArticleId><ArticleId IdType="pmc">PMC8278305</ArticleId><ArticleId IdType="pubmed">34116023</ArticleId></ArticleIdList></Reference><Reference><Citation>Kipnis E., Guery B.P., Tournoys A., Leroy X., Robriquet L., Fialdes P., Neviere R., Fourrier F. Massive alveolar thrombin activation in Pseudomonas aeruginosa-induced acute lung injury. Shock. 2004;21:444–451. doi: 10.1097/00024382-200405000-00008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00024382-200405000-00008</ArticleId><ArticleId IdType="pubmed">15087821</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofstra J.J., Cornet A.D., de Rooy B.F., Vlaar A.P., van der Poll T., Levi M., Zaat S.A., Schultz M.J. Nebulized antithrombin limits bacterial outgrowth and lung injury in Streptococcus pneumoniae pneumonia in rats. Crit. Care. 2009;13:R145. doi: 10.1186/cc8040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc8040</ArticleId><ArticleId IdType="pmc">PMC2784363</ArticleId><ArticleId IdType="pubmed">19740417</ArticleId></ArticleIdList></Reference><Reference><Citation>Camprubí-Rimblas M., Tantinyà N., Guillamat-Prats R., Bringué J., Puig F., Gómez M.N., Blanch L., Artigas A. Effects of nebulized antithrombin and heparin on inflammatory and coagulation alterations in an acute lung injury model in rats. J. Thromb. Haemost. 2020;18:571–583. doi: 10.1111/jth.14685.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14685</ArticleId><ArticleId IdType="pmc">PMC9906372</ArticleId><ArticleId IdType="pubmed">31755229</ArticleId></ArticleIdList></Reference><Reference><Citation>Wygrecka M., Birnhuber A., Seeliger B., Michalick L., Pak O., Schultz A.-S., Schramm F., Zacharias M., Gorkiewicz G., David S., et al. Altered fibrin clot structure and dysregulated fibrinolysis contribute to thrombosis risk in severe COVID-19. Blood Adv. 2022;6:1074–1087. doi: 10.1182/bloodadvances.2021004816.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/bloodadvances.2021004816</ArticleId><ArticleId IdType="pmc">PMC8648369</ArticleId><ArticleId IdType="pubmed">34861681</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurachi K., Davie E.W. Activation of human factor XI (plasma thromboplastin antecedent) by factor XIIa (activated Hageman factor) Biochemistry. 1977;16:5831–5839. doi: 10.1021/bi00645a030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi00645a030</ArticleId><ArticleId IdType="pubmed">588558</ArticleId></ArticleIdList></Reference><Reference><Citation>Konings J., Govers-Riemslag J.W.P., Philippou H., Mutch N.J., Borissoff J.I., Allan P., Mohan S., Tans G., Cate H.T., Ariëns R.A.S. Factor XIIa regulates the structure of the fibrin clot independently of thrombin generation through direct interaction with fibrin. Blood. 2011;118:3942–3951. doi: 10.1182/blood-2011-03-339572.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2011-03-339572</ArticleId><ArticleId IdType="pubmed">21828145</ArticleId></ArticleIdList></Reference><Reference><Citation>Hess R., Wujak L., Hesse C., Sewald K., Jonigk D., Warnecke G., Fieguth H.G., de Maat S., Maas C., Bonella F., et al. Coagulation factor XII regulates inflammatory responses in human lungs. Thromb. Haemost. 2017;117:1896–1907. doi: 10.1160/TH16-12-0904.</Citation><ArticleIdList><ArticleId IdType="doi">10.1160/TH16-12-0904</ArticleId><ArticleId IdType="pubmed">28816340</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenne E., Renné T. Factor XII: A drug target for safe interference with thrombosis and inflammation. Drug Discov. Today. 2014;19:1459–1464. doi: 10.1016/j.drudis.2014.06.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.drudis.2014.06.024</ArticleId><ArticleId IdType="pubmed">24993156</ArticleId></ArticleIdList></Reference><Reference><Citation>Worm M., Köhler E.C., Panda R., Long A., Butler L.M., Stavrou E.X., Nickel K.F., Fuchs T.A., Renné T. The factor XIIa blocking antibody 3F7: A safe anticoagulant with anti-inflammatory activities. Ann. Transl. Med. 2015;3:247. doi: 10.3978/j.issn.2305-5839.2015.09.07.</Citation><ArticleIdList><ArticleId IdType="doi">10.3978/j.issn.2305-5839.2015.09.07</ArticleId><ArticleId IdType="pmc">PMC4620089</ArticleId><ArticleId IdType="pubmed">26605293</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffin J.H., Fernandez J.A., Gale A.J., Mosnier L.O. Activated protein C. J. Thromb. Haemost. 2007;5((Suppl. 1)):73–80. doi: 10.1111/j.1538-7836.2007.02491.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-7836.2007.02491.x</ArticleId><ArticleId IdType="pubmed">17635713</ArticleId></ArticleIdList></Reference><Reference><Citation>Isshiki T., Sakamoto S., Kinoshita A., Sugino K., Kurosaki A., Homma S. Recombinant human soluble thrombomodulin treatment for acute exacerbation of idiopathic pulmonary fibrosis: A retrospective study. Respiration. 2015;89:201–207. doi: 10.1159/000369828.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000369828</ArticleId><ArticleId IdType="pubmed">25659984</ArticleId></ArticleIdList></Reference><Reference><Citation>Ware L.B., Fang X., Matthay M.A. Protein C and thrombomodulin in human acute lung injury. Am. J. Physiol. Lung Cell Mol. Physiol. 2003;285:L514–L521. doi: 10.1152/ajplung.00442.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00442.2002</ArticleId><ArticleId IdType="pubmed">12754194</ArticleId></ArticleIdList></Reference><Reference><Citation>Esmon C.T. Inflammation and the activated protein C anticoagulant pathway. Semin. Thromb. Hemost. 2006;32((Suppl. 1)):49–60. doi: 10.1055/s-2006-939554.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-2006-939554</ArticleId><ArticleId IdType="pubmed">16673266</ArticleId></ArticleIdList></Reference><Reference><Citation>Eckle I., Seitz R., Egbring R., Kolb G., Havemann K. Protein C degradation in vitro by neutrophil elastase. Biol. Chem. Hoppe Seyler. 1991;372:1007–1013. doi: 10.1515/bchm3.1991.372.2.1007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/bchm3.1991.372.2.1007</ArticleId><ArticleId IdType="pubmed">1793515</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi G., Schultz M.J., Levi M., van der Poll T., Millo J.L., Garrard C.S. Protein C in pneumonia. Thorax. 2005;60:705–706. doi: 10.1136/thx.2004.037341.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thx.2004.037341</ArticleId><ArticleId IdType="pmc">PMC1747500</ArticleId><ArticleId IdType="pubmed">16061717</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi G., Wolthuis E.K., Bresser P., Levi M., van der Poll T., Dzoljic M., Vroom M.B., Schultz M.J. Mechanical ventilation with lower tidal volumes and positive end-expiratory pressure prevents alveolar coagulation in patients without lung injury. Anesthesiology. 2006;105:689–695. doi: 10.1097/00000542-200610000-00013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-200610000-00013</ArticleId><ArticleId IdType="pubmed">17006066</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto K., Loskutoff D.J. Extrahepatic expression and regulation of protein C in the mouse. Am. J. Pathol. 1998;15:547–555. doi: 10.1016/S0002-9440(10)65597-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9440(10)65597-6</ArticleId><ArticleId IdType="pmc">PMC1852986</ArticleId><ArticleId IdType="pubmed">9708814</ArticleId></ArticleIdList></Reference><Reference><Citation>Warkentin T.E., Pai M. Shock, acute disseminated intravascular coagulation, and microvascular thrombosis: Is ‘shock liver’ the unrecognized provocateur of ischemic limb necrosis? J. Thromb. Haemost. 2016;14:231–235. doi: 10.1111/jth.13219.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.13219</ArticleId><ArticleId IdType="pubmed">26662371</ArticleId></ArticleIdList></Reference><Reference><Citation>Levi M., Dörffler-Melly J., Reitsma P., Büller H., Florquin S., van der Poll T., Carmeliet P. Aggravation of endotoxin-induced disseminated intravascular coagulation and cytokine activation in heterozygous protein-C-deficient mice. Blood. 2003;101:4823–4827. doi: 10.1182/blood-2002-10-3254.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2002-10-3254</ArticleId><ArticleId IdType="pubmed">12609841</ArticleId></ArticleIdList></Reference><Reference><Citation>Kager L.M., Wiersinga W.J., Roelofs J.J., Meijers J.C.M., Zeerleder S.S., Esmon C.T., Veer C.V., van der Poll T. Endogenous protein C has a protective role during Gram-negative pneumosepsis (melioidosis) J. Thromb. Haemost. 2013;11:282–292. doi: 10.1111/jth.12094.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.12094</ArticleId><ArticleId IdType="pubmed">23216621</ArticleId></ArticleIdList></Reference><Reference><Citation>Wójcik K., Bazan-Socha S., Celejewska-Wójcik N., Górka K., Lichołai S., Polok K., Stachura T., Zaręba L., Dziedzic R., Gradzikiewicz A., et al. Decreased protein C activity, lower ADAMTS13 antigen and free protein S levels accompanied by unchanged thrombin generation potential in hospitalized COVID-19 patients. Thromb. Res. 2023;223:80–86. doi: 10.1016/j.thromres.2023.01.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2023.01.016</ArticleId><ArticleId IdType="pmc">PMC9872442</ArticleId><ArticleId IdType="pubmed">36709678</ArticleId></ArticleIdList></Reference><Reference><Citation>Neyrinck A.P., Liu K.D., Howard J.P., Matthay M.A. Protective mechanisms of activated protein C in severe inflammatory disorders. Br. J. Pharmacol. 2009;4:1034–1047. doi: 10.1111/j.1476-5381.2009.00251.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1476-5381.2009.00251.x</ArticleId><ArticleId IdType="pmc">PMC2785525</ArticleId><ArticleId IdType="pubmed">19466992</ArticleId></ArticleIdList></Reference><Reference><Citation>Robriquet L., Collet F., Tournoys A., Prangère T., Nevière R., Fourrier F., Guery B.P. Intravenous administration of activated protein C in Pseudomonas-induced lung injury: Impact on lung fluid balance and the inflammatory response. Respir. Res. 2006;7:41. doi: 10.1186/1465-9921-7-41.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1465-9921-7-41</ArticleId><ArticleId IdType="pmc">PMC1435891</ArticleId><ArticleId IdType="pubmed">16553944</ArticleId></ArticleIdList></Reference><Reference><Citation>Cerletti C., Tamburrelli C., Izzi B., Gianfagna F., de Gaetano G. Platelet-leukocyte interactions in thrombosis. Thromb. Res. 2012;129:263–266. doi: 10.1016/j.thromres.2011.10.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2011.10.010</ArticleId><ArticleId IdType="pubmed">22075180</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzgerald J.R., Foster T.J., Cox D. The interaction of bacterial pathogens with platelets. Nat. Rev. Microbiol. 2006;4:445–457. doi: 10.1038/nrmicro1425.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro1425</ArticleId><ArticleId IdType="pubmed">16710325</ArticleId></ArticleIdList></Reference><Reference><Citation>Claushuis T.A.M., Van Der Veen A.I., Horn J., Schultz M.J., Houtkooper R.H., Veer C.V., Van Der Poll T. Platelet toll-like receptor expression and activation induced by lipopolysaccharide and sepsis. Platelets. 2019;30:296–304. doi: 10.1080/09537104.2018.1445841.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09537104.2018.1445841</ArticleId><ArticleId IdType="pubmed">29528268</ArticleId></ArticleIdList></Reference><Reference><Citation>Palankar R., Kohler T.P., Krauel K., Wesche J., Hammerschmidt S., Greinacher A. Platelets kill bacteria by bridging innate and adaptive immunity via platelet factor 4 and FcγRIIA. J. Thromb. Haemost. 2018;16:1187–1197. doi: 10.1111/jth.13955.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.13955</ArticleId><ArticleId IdType="pubmed">29350833</ArticleId></ArticleIdList></Reference><Reference><Citation>Tunjungputri R.N., de Jonge M.I., de Greeff A., van Selm S., Buys H., Harders-Westerveen J.F., Stockhofe-Zurwieden N., Urbanus R.T., de Groot P.G., Smith H.E., et al. Invasive pneumococcal disease leads to activation and hyperreactivity of platelets. Thromb. Res. 2016;144:123–126. doi: 10.1016/j.thromres.2016.06.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2016.06.016</ArticleId><ArticleId IdType="pubmed">27322088</ArticleId></ArticleIdList></Reference><Reference><Citation>Cangemi R., Carnevale R., Nocella C., Calvieri C., Cammisotto V., Novo M., Castellani V., D’Amico A., Zerbinati C., Stefanini L., et al. Glucocorticoids impair platelet thromboxane biosynthesis in community-acquired pneumonia. Pharmacol. Res. 2018;131:66–74. doi: 10.1016/j.phrs.2018.03.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2018.03.014</ArticleId><ArticleId IdType="pubmed">29577968</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldman C. Cardiac complications in community-acquired pneumonia and COVID-19. Afr. J. Thorac. Crit. Care Med. 2020;26:1–5. doi: 10.7196/AJTCCM.2020.v26i2.077.</Citation><ArticleIdList><ArticleId IdType="doi">10.7196/AJTCCM.2020.v26i2.077</ArticleId><ArticleId IdType="pmc">PMC7221539</ArticleId><ArticleId IdType="pubmed">34235421</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugiyama M.G., Gamage A., Zyla R., Armstrong S.M., Advani S., Advani A., Wang C., Lee W.L. Influenza Virus Infection Induces Platelet-Endothelial Adhesion Which Contributes to Lung Injury. J. Virol. 2015;90:1812–1823. doi: 10.1128/JVI.02599-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02599-15</ArticleId><ArticleId IdType="pmc">PMC4733979</ArticleId><ArticleId IdType="pubmed">26637453</ArticleId></ArticleIdList></Reference><Reference><Citation>McMullen P.D., Cho J.H., Miller J.L., Husain A.N., Pytel P., Krausz T. A Descriptive and Quantitative Immunohistochemical Study Demonstrating a Spectrum of Platelet Recruitment Patterns Across Pulmonary Infections Including COVID-19. Am. J. Clin. Pathol. 2021;155:354–363. doi: 10.1093/ajcp/aqaa230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcp/aqaa230</ArticleId><ArticleId IdType="pmc">PMC7717231</ArticleId><ArticleId IdType="pubmed">33174599</ArticleId></ArticleIdList></Reference><Reference><Citation>Heikkinen T., Järvinen A. The common cold. Lancet. 2003;361:51–59. doi: 10.1016/S0140-6736(03)12162-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(03)12162-9</ArticleId><ArticleId IdType="pmc">PMC7112468</ArticleId><ArticleId IdType="pubmed">12517470</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreutz R.P., Bliden K.P., Tantry U.S., Gurbel P.A. Viral respiratory tract infections increase platelet reactivity and activation: An explanation for the higher rates of myocardial infarction and stroke during viral illness. J. Thromb. Haemost. 2005;3:2108–2109. doi: 10.1111/j.1538-7836.2005.01474.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-7836.2005.01474.x</ArticleId><ArticleId IdType="pmc">PMC7166489</ArticleId><ArticleId IdType="pubmed">16102122</ArticleId></ArticleIdList></Reference><Reference><Citation>Consolo F., DELLA Valle P., Saracino M., Bonora M., Donadoni G., Ciceri F., Tresoldi M., D’angelo A., Landoni G., Zangrillo A. Platelet activation state in early stages of COVID-19. Minerva Anestesiol. 2022;6:472–478. doi: 10.23736/S0375-9393.22.16054-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.23736/S0375-9393.22.16054-2</ArticleId><ArticleId IdType="pubmed">35315619</ArticleId></ArticleIdList></Reference><Reference><Citation>Campo G., Contoli M., Fogagnolo A., Sega F.V.D., Zucchetti O., Ronzoni L., Verri M., Fortini F., Pavasini R., Morandi L., et al. Over time relationship between platelet reactivity, myocardial injury and mortality in patients with SARS-CoV-2-associated respiratory failure. Platelets. 2021;4:560–567. doi: 10.1080/09537104.2020.1852543.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09537104.2020.1852543</ArticleId><ArticleId IdType="pmc">PMC7754923</ArticleId><ArticleId IdType="pubmed">33270471</ArticleId></ArticleIdList></Reference><Reference><Citation>Iba T., Levy J.H., Connors J.M., Warkentin T.E., Thachil J., Levi M. The unique characteristics of COVID-19 coagulopathy. Crit. Care. 2020;24:360. doi: 10.1186/s13054-020-03077-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03077-0</ArticleId><ArticleId IdType="pmc">PMC7301352</ArticleId><ArticleId IdType="pubmed">32552865</ArticleId></ArticleIdList></Reference><Reference><Citation>Turpie A.G., Esmon C. Venous and arterial thrombosis--pathogenesis and the rationale for anticoagulation. Thromb. Haemost. 2011;105:586–596. doi: 10.1160/TH10-10-0683.</Citation><ArticleIdList><ArticleId IdType="doi">10.1160/TH10-10-0683</ArticleId><ArticleId IdType="pubmed">21225099</ArticleId></ArticleIdList></Reference><Reference><Citation>Jamasbi J., Ayabe K., Goto S., Nieswandt B., Peter K., Siess W. Platelet receptors as therapeutic targets: Past, present and future. Thromb. Haemost. 2017;7:1249–1257. doi: 10.1160/TH16-12-0911.</Citation><ArticleIdList><ArticleId IdType="doi">10.1160/TH16-12-0911</ArticleId><ArticleId IdType="pubmed">28597906</ArticleId></ArticleIdList></Reference><Reference><Citation>Porembskaya O., Zinserling V., Tomson V., Toropova Y., Starikova E.A., Maslei V.V., Bulavinova N.I., Kirik O.V., Syrtsova M.A., Laberko L., et al. Neutrophils Mediate Pulmonary Artery Thrombosis In Situ. Int. J. Mol. Sci. 2022;23:5829. doi: 10.3390/ijms23105829.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23105829</ArticleId><ArticleId IdType="pmc">PMC9144243</ArticleId><ArticleId IdType="pubmed">35628637</ArticleId></ArticleIdList></Reference><Reference><Citation>Khismatullin R.R., Ponomareva A.A., Nagaswami C., Ivaeva R.A., Montone K.T., Weisel J.W., Litvinov R.I. Pathology of lung-specific thrombosis and inflammation in COVID-19. J. Thromb. Haemost. 2021;19:3062–3072. doi: 10.1111/jth.15532.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15532</ArticleId><ArticleId IdType="pmc">PMC8646730</ArticleId><ArticleId IdType="pubmed">34538029</ArticleId></ArticleIdList></Reference><Reference><Citation>Quartuccio L., Sonaglia A., Casarotto L., McGonagle D., Di Loreto C., Pegolo E. Clinical, laboratory and immunohistochemical characterization of in situ pulmonary arterial thrombosis in fatal COVID-19. Thromb. Res. 2022;219:95–101. doi: 10.1016/j.thromres.2022.09.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2022.09.012</ArticleId><ArticleId IdType="pmc">PMC9481474</ArticleId><ArticleId IdType="pubmed">36152461</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuchs T.A., Brill A., Wagner D.D. Neutrophil extracellular trap (NET) impact on deep vein thrombosis. Arterioscler. Thromb. Vasc. Biol. 2012;32:1777–1783. doi: 10.1161/ATVBAHA.111.242859.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.111.242859</ArticleId><ArticleId IdType="pmc">PMC3495595</ArticleId><ArticleId IdType="pubmed">22652600</ArticleId></ArticleIdList></Reference><Reference><Citation>Radermecker C., Detrembleur N., Guiot J., Cavalier E., Henket M., d’Emal C., Vanwinge C., Cataldo D., Oury C., Delvenne P., et al. Neutrophil extracellular traps infiltrate the lung airway, interstitial, and vascular compartments in severe COVID-19. J. Exp. Med. 2020;217:e20201012. doi: 10.1084/jem.20201012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20201012</ArticleId><ArticleId IdType="pmc">PMC7488867</ArticleId><ArticleId IdType="pubmed">32926097</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Kuraishy H.M., Al-Gareeb A.I., Al-Hussaniy H.A., Al-Harcan N.A.H., Alexiou A., Batiha G.E. Neutrophil Extracellular Traps (NETs) and Covid-19: A new frontiers for therapeutic modality. Int. Immunopharmacol. 2022;104:108516. doi: 10.1016/j.intimp.2021.108516.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2021.108516</ArticleId><ArticleId IdType="pmc">PMC8733219</ArticleId><ArticleId IdType="pubmed">35032828</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X., Li T., Chen H., Yuan L., Ao H. Role and intervention of PAD4 in NETs in acute respiratory distress syndrome. Respir. Res. 2024;25:63. doi: 10.1186/s12931-024-02676-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-024-02676-7</ArticleId><ArticleId IdType="pmc">PMC10829387</ArticleId><ArticleId IdType="pubmed">38291476</ArticleId></ArticleIdList></Reference><Reference><Citation>Franchini M., Lippi G. Von Willebrand factor and thrombosis. Ann. Hematol. 2006;85:415–423. doi: 10.1007/s00277-006-0085-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00277-006-0085-5</ArticleId><ArticleId IdType="pubmed">16568319</ArticleId></ArticleIdList></Reference><Reference><Citation>Manz X.D., Bogaard H.J., Aman J. Regulation of VWF (Von Willebrand Factor) in Inflammatory Thrombosis. Arterioscler. Thromb. Vasc. Biol. 2022;42:1307–1320. doi: 10.1161/ATVBAHA.122.318179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.122.318179</ArticleId><ArticleId IdType="pubmed">36172866</ArticleId></ArticleIdList></Reference><Reference><Citation>Tripodi A., Rossi S.C., Clerici M., Merati G., Scalambrino E., Mancini I., Baronciani L., Boscarino M., Monzani V., Peyvandi F. Pro-coagulant imbalance in patients with community acquired pneumonia assessed on admission and one month after hospital discharge. Clin. Chem. Lab. Med. 2021;59:1699–1708. doi: 10.1515/cclm-2021-0538.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/cclm-2021-0538</ArticleId><ArticleId IdType="pubmed">34192831</ArticleId></ArticleIdList></Reference><Reference><Citation>Doevelaar A.A., Bachmann M., Hölzer B., Seibert F.S., Rohn B.J., Bauer F., Witzke O., Dittmer U., Bachmann M., Yilmaz S., et al. von Willebrand Factor Multimer Formation Contributes to Immunothrombosis in Coronavirus Disease 2019. Crit. Care Med. 2021;49:e512–e520. doi: 10.1097/CCM.0000000000004918.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000004918</ArticleId><ArticleId IdType="pubmed">33591004</ArticleId></ArticleIdList></Reference><Reference><Citation>Pham T.T., Punsawad C., Glaharn S., De Meyer S.F., Viriyavejakul P., Van den Steen P.E. Release of endothelial activation markers in lungs of patients with malaria-associated acute respiratory distress syndrome. Malar. J. 2019;18:395. doi: 10.1186/s12936-019-3040-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12936-019-3040-3</ArticleId><ArticleId IdType="pmc">PMC6891978</ArticleId><ArticleId IdType="pubmed">31796023</ArticleId></ArticleIdList></Reference><Reference><Citation>Favaloro E.J., Henry B.M., Lippi G. Increased VWF and Decreased ADAMTS-13 in COVID-19: Creating a Milieu for (Micro)Thrombosis. Semin. Thromb. Hemost. 2021;47:400–418. doi: 10.1055/s-0041-1727282.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0041-1727282</ArticleId><ArticleId IdType="pubmed">33893632</ArticleId></ArticleIdList></Reference><Reference><Citation>Babkina A.S., Ostrova I.V., Yadgarov M.Y., Kuzovlev A.N., Grechko A.V., Volkov A.V., Golubev A.M. The Role of Von Willebrand Factor in the Pathogenesis of Pulmonary Vascular Thrombosis in COVID-19. Viruses. 2022;14:211. doi: 10.3390/v14020211.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14020211</ArticleId><ArticleId IdType="pmc">PMC8874644</ArticleId><ArticleId IdType="pubmed">35215805</ArticleId></ArticleIdList></Reference><Reference><Citation>Lüttge M., Fulde M., Talay S.R., Nerlich A., Rohde M., Preissner K.T., Hammerschmidt S., Steinert M., Mitchell T.J., Chhatwal G.S., et al. Streptococcus pneumoniae induces exocytosis of Weibel-Palade bodies in pulmonary endothelial cells. Cell Microbiol. 2012;14:210–225. doi: 10.1111/j.1462-5822.2011.01712.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1462-5822.2011.01712.x</ArticleId><ArticleId IdType="pubmed">21999205</ArticleId></ArticleIdList></Reference><Reference><Citation>Martens C.P., Peetermans M., Vanassche T., Verhamme P., Jacquemin M., Martinod K. Peptidylarginine deiminase 4 and ADAMTS13 activity in Staphylococcusaureus bacteraemia. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 2023;378:20230042. doi: 10.1098/rstb.2023.0042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rstb.2023.0042</ArticleId><ArticleId IdType="pmc">PMC10542450</ArticleId><ArticleId IdType="pubmed">37778390</ArticleId></ArticleIdList></Reference><Reference><Citation>Golubev A.M., Moroz V.V., Lysenko D.V., Kuzovlev A.N., Ostapchenko D.A. Artificial Ventilation-Induced Acute Lung Lesion: Experimental, Morphological Study. Gen. Reanimatol. 2006;2:8–12. doi: 10.15360/1813-9779-2006-4-8-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.15360/1813-9779-2006-4-8-12</ArticleId></ArticleIdList></Reference><Reference><Citation>Cepkova M., Brady S., Sapru A., Matthay M.A., Church G. Biological markers of lung injury before and after the institution of positive pressure ventilation in patients with acute lung injury. Crit. Care. 2006;10:R126. doi: 10.1186/cc5037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc5037</ArticleId><ArticleId IdType="pmc">PMC1751077</ArticleId><ArticleId IdType="pubmed">16956410</ArticleId></ArticleIdList></Reference><Reference><Citation>Ware L.B., Conner E.R., Matthay M.A. von Willebrand factor antigen is an independent marker of poor outcome in patients with early acute lung injury. Crit. Care Med. 2001;29:2325–2331. doi: 10.1097/00003246-200112000-00016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-200112000-00016</ArticleId><ArticleId IdType="pubmed">11801836</ArticleId></ArticleIdList></Reference><Reference><Citation>Yiming M.T., Lederer D.J., Sun L., Huertas A., Issekutz A.C., Bhattacharya S. Platelets enhance endothelial adhesiveness in high tidal volume ventilation. Am. J. Respir. Cell Mol. Biol. 2008;39:569–575. doi: 10.1165/rcmb.2007-0332OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1165/rcmb.2007-0332OC</ArticleId><ArticleId IdType="pmc">PMC2574527</ArticleId><ArticleId IdType="pubmed">18483418</ArticleId></ArticleIdList></Reference><Reference><Citation>Onodera Y., Mitani S., Hosoda C., Takabayashi Y., Sakata A., Kawasaki R., Mori R., Ohshima C., Nishio K., Sugimoto M., et al. Regulation of von Willebrand factor by ADAMTS13 ameliorates lipopolysaccharide-induced lung injury in mice. Int. J. Hematol. 2023;118:699–710. doi: 10.1007/s12185-023-03668-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12185-023-03668-x</ArticleId><ArticleId IdType="pubmed">37759076</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y.M., Jiang M., Ji S.D., He Y., Shen F., Li X.M., Ruan C.G. Anti-human VWF monoclonal antibody SZ-123 prevents arterial thrombus formation by inhibiting VWF-collagen and VWF-platelet interactions in Rhesus monkeys. Biochem. Pharmacol. 2013;7:945–953. doi: 10.1016/j.bcp.2012.12.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2012.12.022</ArticleId><ArticleId IdType="pubmed">23295157</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J., Reheman A., Gushiken F.C., Nolasco L., Fu X., Moake J.L., Ni H., López J.A. N-acetylcysteine reduces the size and activity of von Willebrand factor in human plasma and mice. J. Clin. Investig. 2011;2:593–603. doi: 10.1172/JCI41062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI41062</ArticleId><ArticleId IdType="pmc">PMC3026714</ArticleId><ArticleId IdType="pubmed">21266777</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim D., Shea S.M., Ku D.N. Lysis of arterial thrombi by perfusion of N,N’-Diacetyl-L-cystine (DiNAC) PLoS ONE. 2021;16:e0247496. doi: 10.1371/journal.pone.0247496.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0247496</ArticleId><ArticleId IdType="pmc">PMC7906380</ArticleId><ArticleId IdType="pubmed">33630932</ArticleId></ArticleIdList></Reference><Reference><Citation>Elabbadi A., Turpin M., Gerotziafas G.T., Teulier M., Voiriot G., Fartoukh M. Bacterial coinfection in critically ill COVID-19 patients with severe pneumonia. Infection. 2021;49:559–562. doi: 10.1007/s15010-020-01553-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-020-01553-x</ArticleId><ArticleId IdType="pmc">PMC7779094</ArticleId><ArticleId IdType="pubmed">33393065</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu X., Liu M., Wang Q., Zhang Y., Kong L., Zhou L. Thrombosis in Critically Ill Influenza Patients: Incidence and Risk Factors. Clin. Appl. Thromb. Hemost. 2024;30:10760296241278615. doi: 10.1177/10760296241278615.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/10760296241278615</ArticleId><ArticleId IdType="pmc">PMC11348485</ArticleId><ArticleId IdType="pubmed">39183536</ArticleId></ArticleIdList></Reference><Reference><Citation>Walters K.A., D’Agnillo F., Sheng Z.M., Kindrachuk J., Schwartzman L.M., Kuestner R.E., Chertow D.S., Golding B.T., Taubenberger J.K., Kash J.C. 1918 pandemic influenza virus and Streptococcus pneumoniae co-infection results in activation of coagulation and widespread pulmonary thrombosis in mice and humans. J. Pathol. 2016;238:85–97. doi: 10.1002/path.4638.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.4638</ArticleId><ArticleId IdType="pmc">PMC4789761</ArticleId><ArticleId IdType="pubmed">26383585</ArticleId></ArticleIdList></Reference><Reference><Citation>Narayana Moorthy A.N., Narasaraju T., Rai P., Perumalsamy R., Tan K.B., Wang S., Engelward B., Chow V.T.K. In vivo and in vitro studies on the roles of neutrophil extracellular traps during secondary pneumococcal pneumonia after primary pulmonary influenza infection. Front. Immunol. 2013;4:56. doi: 10.3389/fimmu.2013.00056.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2013.00056</ArticleId><ArticleId IdType="pmc">PMC3587798</ArticleId><ArticleId IdType="pubmed">23467809</ArticleId></ArticleIdList></Reference><Reference><Citation>Babkina A.S., Golubev A.M., Ostrova I.V., Volkov A.V., Kuzovlev A.N. Brain Morphological Changes in COVID-19. Gen. Reanimatol. 2021;17:4–15. doi: 10.15360/1813-9779-2021-3-1-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.15360/1813-9779-2021-3-1-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattila K.J., Valtonen V.V., Nieminen M.S., Asikainen S. Role of infection as a risk factor for atherosclerosis, myocardial infarction, and stroke. Clin. Infect. Dis. 1998;26:719–734. doi: 10.1086/514570.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/514570</ArticleId><ArticleId IdType="pubmed">9524851</ArticleId></ArticleIdList></Reference><Reference><Citation>De Lourdes Higuchi M., Ramires J.A. Infectious agents in coronary atheromas: A possible role in the pathogenesis of plaque rupture and acute myocardial infarction. Rev. Inst. Med. Trop. Sao Paulo. 2002;44:217–224. doi: 10.1590/S0036-46652002000400007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S0036-46652002000400007</ArticleId><ArticleId IdType="pubmed">12219114</ArticleId></ArticleIdList></Reference><Reference><Citation>Gattinoni L., Chiumello D., Caironi P., Busana M., Romitti F., Brazzi L., Camporota L. COVID-19 pneumonia: Different respiratory treatments for different phenotypes? Intensive Care Med. 2020;46:1099–1102. doi: 10.1007/s00134-020-06033-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-06033-2</ArticleId><ArticleId IdType="pmc">PMC7154064</ArticleId><ArticleId IdType="pubmed">32291463</ArticleId></ArticleIdList></Reference><Reference><Citation>Hariri L., Hardin C.C. Covid-19, Angiogenesis, and ARDS Endotypes. N. Engl. J. Med. 2020;383:182–183. doi: 10.1056/NEJMe2018629.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMe2018629</ArticleId><ArticleId IdType="pubmed">32437597</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>